📰 Aldx News
Page 5 - Aldx News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aldx. Real-time updates on events, politics, business and more.
May 1, 2023
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating)’s stock price traded up 6.4% on Monday . The stock traded as high as $10.14 and last traded at $10.14. 368,965 shares changed hands during trading, a decline of 47% from the average session volume of 696,185 shares. The stock had previously closed at $9.53. Analyst Upgrades and […]
April 7, 2023
Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $7.43 and traded as high as $9.87. Aldeyra Therapeutics shares last traded at $9.73, with a volume of 832,726 shares trading hands. Analysts Set New […]
April 2, 2023
2023 is shaping up to be a pivotal year for Aldeyra Therapeutics Inc. (ALDX) as it continues to make significant progress in its pipeline of compounds targeting systemic and retinal immune-mediated diseases.
March 27, 2023
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) saw unusually-strong trading volume on Monday . Approximately 712,812 shares changed hands during trading, an increase of 44% from the previous session’s volume of 493,919 shares.The stock last traded at $8.61 and had previously closed at $9.03. Analyst Upgrades and Downgrades A number of research analysts have issued […]
March 17, 2023
The global banking fallout is pushing investors back into safe haven assets like gold.
March 13, 2023
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) – Oppenheimer issued their Q1 2023 EPS estimates for shares of Aldeyra Therapeutics in a report issued on Thursday, March 9th. Oppenheimer analyst J. Kim expects that the biotechnology company will post earnings of ($0.26) per share for the quarter. The consensus estimate for Aldeyra Therapeutics’ current full-year […]
November 2, 2022
Seasoned traders who understand risk could nibble on the long side of ALDX....ALDX
June 2, 2022
Wall Street analysts expect Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) to report earnings of ($0.32) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Aldeyra Therapeutics’ earnings, with the highest EPS estimate coming in at ($0.29) and the lowest estimate coming in at ($0.36). Aldeyra Therapeutics […]
April 6, 2022
Kestra Advisory Services LLC increased its stake in shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) by 33.4% during the 4th quarter, Holdings Channel reports. The fund owned 16,809 shares of the biotechnology company’s stock after acquiring an additional 4,212 shares during the period. Kestra Advisory Services LLC’s holdings in Aldeyra Therapeutics were worth […]
March 18, 2022
Aldeyra Therapeutics (NASDAQ:ALDX – Get Rating) posted its earnings results on Thursday. The biotechnology company reported ($0.27) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.01, MarketWatch Earnings reports. During the same quarter last year, the firm earned ($0.35) earnings per share. ALDX stock traded up $0.19 during mid-day […]